News
Zepbound Outperforms Wegovy in Head-to-Head Weight Loss Study
A new study has found that people taking Eli Lilly’s obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk’s Wegovy. The study — published May 11 in the New England Journal of Medicine — followed 751 people across the U.
GLP-1 drugs achieve some of these effects by directly affecting the brain’s cravings for food, and that might also extend to ...
David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic ...
The best metric is not weight, but a particularly toxic kind of fat.
Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on "CBS Mornings Plus." ...
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...
"Cleared after 38 yrs" is the headline for the Daily Mirror, which describes Peter Sullivan's ordeal as a "justice fiasco".
GLP-1 medications like semaglutide and tirzepatide have exploded in popularity, with millions of Americans turning to them for weight loss. But are they the magic bullet for sustainable results? The ...
Health on MSN2h
Why You Might Tolerate One Weight Loss Drug Better Than Another, According to ExpertsFact checked by Nick Blackmer Tirzepatide and semaglutide, the ingredients in popular weight loss drugs, can both cause side ...
According to a recent Kaiser Family Foundation poll, roughly 6% of U.S. adults are currently taking GLP-1 for weight loss, ...
Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback